How Mounjaro Works
Mounjaro works differently than a GLP-1 RA1
Tirzepatide is the first and only approved single molecule that activates GIP and GLP-1 receptors in the body.1
Mounjaro acts in the following ways1
1. ENHANCES
insulin secretion
2. IMPROVES
insulin sensitivity.
3. DECREASES
food intake.
Additional actions include delayed gastric emptying* and reduced glucagon levels.
Resulting in lower glucose concentration in both fasting and postprandial states.
*This effect diminishes over time.
GIP=glucose-dependent insulinotropic polypeptide; GLP-1=glucagon-like peptide-1; RA=receptor agonist; T2D=type 2 diabetes.
Reference:
- Mounjaro. Prescribing Information. Lilly USA, LLC.